BIOMAT Database Logo BIOMAT Database Logo

[Fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta 15-42)]. 1995

N Tatsumi, and N Hirai, and Y Tatsumi
Department of Clinical Hematology, Osaka City University Medical School.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005344 Fibrinopeptide A Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin. Fibrinopeptides A
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Tatsumi, and N Hirai, and Y Tatsumi
[Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
N Tatsumi, and N Hirai, and Y Tatsumi
[FPA (fibrinopeptide A) and B beta 15-42)].
April 1987, Rinsho byori. The Japanese journal of clinical pathology,
N Tatsumi, and N Hirai, and Y Tatsumi
Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
October 1986, The Tokai journal of experimental and clinical medicine,
N Tatsumi, and N Hirai, and Y Tatsumi
[Fibrinopeptide A, fibrinopeptide B beta 15-42].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
N Tatsumi, and N Hirai, and Y Tatsumi
[Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
May 1988, Masui. The Japanese journal of anesthesiology,
N Tatsumi, and N Hirai, and Y Tatsumi
[Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
April 1988, Masui. The Japanese journal of anesthesiology,
N Tatsumi, and N Hirai, and Y Tatsumi
[Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42].
March 1989, Rinsho byori. The Japanese journal of clinical pathology,
N Tatsumi, and N Hirai, and Y Tatsumi
Fibrinopeptide A and fibrinopeptide B beta 15-42 in patients with Behçet's disease.
January 1988, Metabolic, pediatric, and systemic ophthalmology (New York, N.Y. : 1985),
N Tatsumi, and N Hirai, and Y Tatsumi
Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
January 1988, Haemostasis,
N Tatsumi, and N Hirai, and Y Tatsumi
[Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
June 1986, Nippon Ganka Gakkai zasshi,
Copied contents to your clipboard!